Molecular Characterization of ERBB2 -Amplified Colorectal Cancer Identifies Potential Mechanisms of Resistance to Targeted Therapies: A Report of Two Instructive Cases

Cold Spring Harbor molecular case studies - United States
doi 10.1101/mcs.a002535
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Targeted Therapies in Cancer and Mechanisms of Resistance

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2014English

Dissecting Mechanisms of Resistance to Targeted Drug Combination Therapy in Human Colorectal Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer

Cancer Research
Cancer ResearchOncology
2016English

CRADA Final Report: ErbB2 Targeted Cancer Therapeutics

2002English

Ovarian Cancer: Emerging Molecular-Targeted Therapies

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

Molecular Targeted Therapies for Pancreatic Cancer

American Journal of Surgery
MedicineSurgery
2008English

Proteogenomic Systems Analysis Identifies Targeted Therapy Resistance Mechanisms in EGFR-mutated Lung Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

Cholangiociliopathies: Genetics, Molecular Mechanisms and Potential Therapies

Current Opinion in Gastroenterology
Gastroenterology
2009English

Molecular Mechanisms of Cardiovascular Toxicity of Targeted Cancer Therapeutics

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy